Hidradenitis suppurativa alias acne inversa – A review
Hidradenitis suppurativa alias acne inversa
Keywords:
Hidradenitis Suppurativa, Acne Inversa, Scar, Abscess, Pseudocomedones, Sinus Tract, Biologics, Microbiome, StagingAbstract
Hidradenitis suppurativa (HS), also called acne inversus, is a distressing chronic inflammatory skin condition with lesions including deep-seated nodules and abscesses, sinuses, and fibrotic scars. These lesions most commonly manifest in apocrine gland rich intertriginous locations. Because of the chronicity, associated pain, sensitive locations, malodourous drainage, and scarring, this condition has a significant negative impact on patients’ quality of life. The exact pathogenic mechanisms remain incompletely understood and hence, the efficient management modalities are still lacking. The current manuscript reviews the epidemiology, aetiopathogenesis, clinical presentation, and current treatment modalities of hidradenitis suppurativa.References
References
Goldburg SR, Strober BE, Payette MJ. Hidradenitis suppurativa: Epidemiology, clinical presentation, and pathogenesis. J Am Acad Dermatol. 2020 May;82(5):1045-1058.
Anduquia-Garay F, Rodríguez-Gutiérrez MM, Poveda-Castillo IT, Valdes-Moreno PL, Agudelo-Rios DA, Benavides-Moreno JS, Lozada-Martínez ID, Bolaño-Romero MP, Borraez-Segura B, Rahman S. Hidradenitis suppurativa: Basic considerations for its approach: A narrative review. Ann Med Surg (Lond). 2021 Aug 5;68:102679.
Napolitano M, Megna M, Timoshchuk EA, Patruno C, Balato N, Fabbrocini G, Monfrecola G. Hidradenitis suppurativa: from pathogenesis to diagnosis and treatment. Clin Cosmet Investig Dermatol. 2017 Apr 19;10:105-115.
Jemec GB, Kimball AB. Hidradenitis suppurativa: Epidemiology and scope of the problem. J Am Acad Dermatol. 2015 Nov;73(5 Suppl 1):S4-7.
Dufour DN, Emtestam L, Jemec GB: Hidradenitis suppurativa: a common and burdensome, yet under-recognised, inflammatory skin disease. Post Grad Med J 2014;90:216-221.
Włodarek K, Głowaczewska A, Matusiak Ł, Szepietowski JC. Psychosocial burden of Hidradenitis Suppurativa patients' partners. J Eur Acad Dermatol Venereol. 2020 Aug;34(8):1822-1827.
Preda-Naumescu A, Ahmed HN, Mayo TT, Yusuf N. Hidradenitis suppurativa: pathogenesis, clinical presentation, epidemiology, and comorbid associations. Int J Dermatol. 2021 Nov;60(11):e449-e458.
Fimmel S, Zouboulis CC. Comorbidities of hidradenitis suppurativa (acne inversa). Dermatoendocrinol. 2010 Jan;2(1):9-16.
Bazex J, Bayle P, San B. Hidradenitis suppurativa is acne inversa. Int J Dermatol. 2007 Mar;46(3):330.
Sellheyer K, Krahl D. "Hidradenitis suppurativa" is acne inversa! An appeal to (finally) abandon a misnomer. Int J Dermatol. 2005 Jul;44(7):535-40.
von Laffert M, Stadie V, Wohlrab J, Marsch WC. Hidradenitis suppurativa/acne inversa: bilocated epithelial hyperplasia with very different sequelae. Br J Dermatol. 2011 Feb;164(2):367-71.
Chen W, Plewig G. Should hidradenitis suppurativa/acne inversa best be renamed as "dissecting terminal hair folliculitis"? Exp Dermatol. 2017 Jun;26(6):544-547.
Kurokawa I, Hayashi N; Japan Acne Research Society. Questionnaire surveillance of hidradenitis suppurativa in Japan. J Dermatol. 2015 Jul;42(7):747-9.
Lee JH, Kwon HS, Jung HM, Kim GM, Bae JM. Prevalence and comorbidities associated with hidradenitis suppurativa in Korea: a nationwide population-based study. J Eur Acad Dermatol Venereol. 2018 Oct;32(10):1784-1790.
Garg A, Kirby JS, Lavian J, Lin G, Strunk A. Sex- and Age-Adjusted Population Analysis of Prevalence Estimates for Hidradenitis Suppurativa in the United States. JAMA Dermatol. 2017 Aug 1;153(8):760-764.
Garg A, Lavian J, Lin G, Strunk A, Alloo A. Incidence of hidradenitis suppurativa in the United States: A sex- and age-adjusted population analysis. J Am Acad Dermatol. 2017 Jul;77(1):118-122.
Garg A, Wertenteil S, Baltz R, Strunk A, Finelt N. Prevalence Estimates for Hidradenitis Suppurativa among Children and Adolescents in the United States: A Gender- and Age-Adjusted Population Analysis. J Invest Dermatol. 2018 Oct;138(10):2152-2156.
Vuong CL, Park HH, Zhang S, Conic RRZ, Hightower GK. Neighborhood-based analysis of adolescent hidradenitis suppurativa prevalence in a large metropolitan area. JAAD Int. 2022 Aug 30;9:80-81.
Deckers I.E., van der Zee H.H., Prens E.P. Epidemiology of hidradenitis suppurativa: prevalence, pathogenesis, and factors associated with the development of HS. Curr. Derm. Rep. 2013; 3:54–60.
Von Der Werth JM, Williams HC, Raeburn JA. The clinical genetics of hidradenitis suppurativa revisited. Br J Dermatol. 2000; 142:947–953.
Gao M, Wang PG, Cui Y, Yang S, Zhang YH, Lin D, Zhang KY, Liang YH, Sun LD, Yan KL, Xiao FL, Huang W, Zhang XJ. Inversa acne (hidradenitis suppurativa): a case report and identification of the locus at chromosome 1p21.1-1q25.3. J Invest Dermatol. 2006 Jun;126(6):1302-6.
Li X, Jiang L, Huang Y, Ren Z, Liang X, Wang P. A gene dysfunction module reveals the underlying pathogenesis of hidradenitis suppurativa: An update. Australas J Dermatol. 2020 Feb;61(1):e10-e14.
Lee E.Y., Alhusayen R., Lansang P., Shear N., Yeung J. What is hidradenitis suppurativa? Can. Fam. Physician. 2017;63(2):114–120.
van der Zee HH, Laman JD, de Ruiter L, Dik WA, Prens EP. Adalimumab (antitumour necrosis factor-α) treatment of hidradenitis suppurativa ameliorates skin inflammation: an in situ and ex vivo study. Br J Dermatol. 2012;166:298–305.
Melnik BC, Plewig G. Impaired Notch-MKP-1 signalling in hidradenitis suppurativa: an approach to pathogenesis by evidence from translational biology. Exp Dermatol. 2013; 22:172–177.
Pan Y, Lin MH, Tian X, et al. Gamma-secretase functions through Notch signaling to maintain skin appendages but is not required for their patterning or initial morphogenesis. Dev Cell. 2004; 7:731–743.
Schlapbach C, Hänni T, Yawalkar N, Hunger RE. Expression of the IL-23/Th17 pathway in lesions of hidradenitis suppurativa. J Am Acad Dermatol. 2011; 65:790–798.
Mozeika E, Pilmane M, Nürnberg BM, Jemec GB. Tumour necrosis factor-alpha and matrix metalloproteinase-2 are expressed strongly in hidradenitis suppurativa. Acta Derm Venereol. 2013;93:301–304.
Freiman A, Bird G, Metelitsa AI, Barankin B, Lauzon G. Cutaneous effects of smoking. Surgery. 2004;8:415–423.
Revuz JE, Canoui-Poitrine F, Wolkenstein P, Viallette C, Gabison G, Pouget F, Poli F, Faye O, Roujeau JC, Bonnelye G, Grob JJ, Bastuji-Garin S. Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies. J Am Acad Dermatol. 2008 Oct;59(4):596-601.
Wiseman MC. Hidradenitis suppurativa: a review. Dermatol Ther. 2004;17:50–54.
Benzecry V, Grancini A, Guanziroli E, et al. Hidradenitis suppurativa/acne inversa: a prospective bacteriological study and review of the literature. G Ital Dermatol Venereol. 2020;155(4):459–463.
Danby F.W., Margesson L.J. Hidradenitis suppurativa. Dermatol. Clin. 2010;28(4):779–793.
Morgan WP, Leicester G. The role of depilation and deodorants in hidradenitis suppurativa. Arch Dermatol 1982;118:101–102.
Cutler B, Hagstrom E, Greiling TM. Deodorant/antiperspirant use and hair removal practices for hidradenitis suppurativa: recommendations from a single-center survey. Int J Womens Dermatol. 2023 Jan 10;9(1):e028.
Deckers IE, Janse IC, van der Zee HH, Nijsten T, Boer J, Horváth B, Prens EP. Hidradenitis suppurativa (HS) is associated with low socioeconomic status (SES): A cross-sectional reference study. J Am Acad Dermatol. 2016 Oct;75(4):755-759.e1.
Wertenteil S, Strunk A, Garg A. Association of Low Socioeconomic Status With Hidradenitis Suppurativa in the United States. JAMA Dermatol. 2018 Sep 1;154(9):1086-1088.
Kromann CB, Deckers IE, Esmann S, Boer J, Prens EP, Jemec GB. Risk factors, clinical course and long-termprognosis in hidradenitis suppurativa: a cross-sectional study. Br J Dermatol. 2014 Oct;171(4):819-24.
Alikhan A, Lynch PJ, Eisen DB. Hidradenitis suppurativa: a comprehensive review. J Am Acad Dermatol 2009;60(4):539-61.
Chiricozzi A, Micali G, Veraldi S. The patient journey: a voyage from diagnosis to hidradenitis suppurativa multidisciplinary unit. J Eur Acad Dermatol Venereol. 2019 Oct;33 Suppl 6:15-20.
Saunte DM, Boer J, Stratigos A, Szepietowski JC, Hamzavi I, Kim KH, Zarchi K, Antoniou C, et al. Diagnostic delay in hidradenitis suppurativa is a global problem. Br J Dermatol. 2015 Dec;173(6):1546-9.
Kokolakis G, Wolk K, Schneider-Burrus S, Kalus S, Barbus S, Gomis-Kleindienst S, Sabat R. Delayed Diagnosis of Hidradenitis Suppurativa and Its Effect on Patients and Healthcare System. Dermatology. 2020;236(5):421-430.
Zimman S, Comparatore MV, Vulcano AF, Absi ML, Mazzuoccolo LD. Hidradenitis Suppurativa: Estimated Prevalence, Clinical Features, Concomitant Conditions, and Diagnostic Delay in a University Teaching Hospital in Buenos Aires, Argentina. Actas Dermosifiliogr (Engl Ed). 2019 May;110(4):297-302.
van Straalen KR, Ingram JR, Augustin M, Zouboulis CC. New treatments and new assessment instruments for Hidradenitis suppurativa. Exp Dermatol. 2022 Sep;31 Suppl 1(Suppl 1):33-39.
Hurley HJ. Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa, and familial benign pemphigus: surgical approach. In: Roenigk RK, Roenigk HH, editors. Dermatologic Surgery. New York: Marcel Dekker; 1996. pp. 623–645.
Sartorius K, Lapins J, Emtestam L, Jemec GB. Suggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativa. Br J Dermatol. 2003;149:211–213.
Sartorius K, Emtestam L, Jemec GB, Lapins J. Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity. Br J Dermatol. 2009;161:831–839.
van der Zee HH, Laman JD, Boer J, Prens EP. Hidradenitis suppurativa: viewpoint on clinical phenotyping, pathogenesis and novel treatments. Exp Dermatol. 2012;21:735–739.
Shaver RL, Jemec GBE, Freese R, Alavi A, Lowes MA, Goldfarb N. A survey of clinicians regarding preferred severity assessment tools for hidradenitis suppurativa. Int J Dermatol. 2021 Jun;60(6):e248-e251.
Goldfarb N, Lowes MA, Butt M, King T, Alavi A, Kirby JS. Hidradenitis Suppurativa Area and Severity Index Revised (HASI-R): psychometric property assessment. Br J Dermatol. 2021 May;184(5):905-912.
Kirby JS, Butt M, King T. Severity and Area Score for Hidradenitis (SASH): a novel outcome measurement for hidradenitis suppurativa. Br J Dermatol. 2020 Apr;182(4):940-948.
Horváth B, Janse IC, Blok JL, Driessen RJ, Boer J, Mekkes JR, Prens EP, van der Zee HH. Hurley Staging Refined: A Proposal by the Dutch Hidradenitis Suppurativa Expert Group. Acta Derm Venereol. 2017 Mar 10;97(3):412-413.
Rondags A, Volkering RJ, Turcan I, Zuidema YS, Janse IC, Horvath B. The Refined Hurley Patient Questionnaire: An Accurate Self-assessment Instrument for Deriving the Correct Refined Hurley Stage in Hidradenitis Suppurativa. Acta Derm Venereol. 2019 Jun 1;99(7):703-704.
Dessinioti C, Katsambas A, Antoniou C. Hidradenitis suppurrativa (acne inversa) as a systemic disease. Clin Dermatol. 2014 May-Jun;32(3):397-408.
Shlyankevich J, Chen AJ, Kim GE, Kimball AB. Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis. J Am Acad Dermatol. 2014;71(6):1144–1150.
Kohorst JJ, Kimball AB, Davis MD. Systemic associations of hidradenitis suppurativa. J Am Acad Dermatol. 2015 Nov;73(5 Suppl 1):S27-35.
Miller IM, Ellervik C, Vinding GR, et al. Association of metabolic syndrome and hidradenitis suppurativa. JAMA Dermatol. 2014; 150:1273–1280.
Gold DA, Reeder VJ, Mahan MG, Hamzavi IH. The prevalence of metabolic syndrome in patients with hidradenitis suppurativa. J Am Acad Dermatol. 2014; 70:699–703.
Deckers IE, Benhadou F, Koldijk MJ, Del Marmol V, Horváth B, Boer J, van der Zee HH, Prens EP. Inflammatory bowel disease is associated with hidradenitis suppurativa: Results from a multicenter cross-sectional study. J Am Acad Dermatol. 2017 Jan;76(1):49-53.
Scheinfeld N. Hidradenitis suppurativa: a practical review of possible medical treatments based on over 350 hidradenitis patients. Dermatol Online J. 2013;19:1.
Sabat R, Chanwangpong A, Schneider-Burrus S, et al. Increased prevalence of metabolic syndrome in patients with acne inversa. PLoS One. 2012;7:e31810.
Egeberg A, Gislason GH, Hansen PR. Risk of major adverse cardiovascular events and all-cause mortality in patients with hidradenitis suppurativa. JAMA Dermatol. 2016;152(4):429–434.
Reddy S, Strunk A, Jemec GBE, Garg A. Incidence of Myocardial Infarction and Cerebrovascular Accident in Patients With Hidradenitis Suppurativa. JAMA Dermatol. 2020 Jan 1;156(1):65-71.
Kridin K, Valido K, Cohen JM, Cohen AD. Hidradenitis suppurativa and the risk of myocardial infarction, cerebrovascular accident, and peripheral vascular disease: a population-based study. Arch Dermatol Res. 2023 Apr;315(3):429-435.
Tugnoli S, Agnoli C, Silvestri A, Giari S, Bettoli V, Caracciolo S. Anger, Emotional Fragility, Self-esteem, and Psychiatric Comorbidity in Patients with Hidradenitis Suppurativa/Acne Inversa. J Clin Psychol Med Settings. 2020 Sep;27(3):527-540.
Ooi XT, Choi E, Han H, Ahmad H, Patwardhan KR, Chandran NS. The psychosocial burden of hidradenitis suppurativa in Singapore. JAAD Int. 2022 Dec 7;10:89-94.
Frings VG, Bauer B, Glöditzsch M, Goebeler M, Presser D. Assessing the psychological burden of patients with hidradenitis suppurativa. Eur J Dermatol. 2019 Jun 1;29(3):294-301.
Shavit E, Dreiher J, Freud T, Halevy S, Vinker S, Cohen AD. Psychiatric comorbidities in 3207 patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2015 Feb;29(2):371-376.
Kurek A, Johanne Peters EM, Sabat R, Sterry W, Schneider-Burrus S. Depression is a frequent co-morbidity in patients with acne inversa. J Dtsch Dermatol Ges. 2013 Aug;11(8):743-9, 743-50.
Tzur Bitan D, Berzin D, Cohen AD. Hidradenitis suppurativa and schizophrenia: a nationwide cohort study. J Eur Acad Dermatol Venereol. 2020 Mar;34(3):574-579.
Tzur Bitan D, Berzin D, Cohen A. Hidradenitis Suppurativa and Bipolar Disorders: A Population-Based Study. Dermatology. 2020;236(4):298-304.
Yadav S, Singh S, Edakkanambeth Varayil J, Harmsen WS, Zinsmeister AR, Tremaine WJ, Davis MD, Wetter DA, Colombel JF, Loftus EV Jr. Hidradenitis Suppurativa in Patients With Inflammatory Bowel Disease: A Population-Based Cohort Study in Olmsted County, Minnesota. Clin Gastroenterol Hepatol. 2016 Jan;14(1):65-70.
Kamal N, Cohen BL, Buche S, Delaporte E, Colombel JF. Features of patients with Crohn’s disease and hidradenitis suppurativa. Clin Gastroenterol Hepatol. 2016;14(1):71–79.
Hsiao JL, Antaya RJ, Berger T, Maurer T, Shinkai K, Leslie KS. Hidradenitis suppurativa and concomitant pyoderma gangrenosum: a case series and literature review. Arch Dermatol. 2010;146(11):1265–1270.
Bao B, Zhu C, Shi J, Lu C. Causal association between inflammatory bowel disease and hidradenitis suppurativa: A two-sample bidirectional Mendelian randomization study. Front Immunol. 2023 Jan 26;14:1071616.
Richette P, Molto A, Viguier M, Dawidowicz K, Hayem G, Nassif A, Wendling D, Aubin F, Lioté F, Bachelez H. Hidradenitis suppurativa associated with spondyloarthritis -- results from a multicenter national prospective study. J Rheumatol. 2014 Mar;41(3):490-4.
Rondags A, Arends S, Wink FR, Horváth B, Spoorenberg A. High prevalence of hidradenitis suppurativa symptoms in axial spondyloarthritis patients: A possible new extra-articular manifestation. Semin Arthritis Rheum. 2019 Feb;48(4):611-617.
Constantinou C, Widom K, Desantis J, Obmann M. Hidradenitis suppurativa complicated by squamous cell carcinoma. Am Surg. 2008;74(12):1177–1181.
Ben AJ, Bouasker I, Najah H, Zribi H, Bedoui R, Guesmi F, Hani MA, Nouira R, Zoghlami A, Najah N. Squamous cell carcinoma arising in Verneuil's disease. Tunis Med. 2008 Feb;86(2):169-70.
Atri S, Ben Mahmoud A, Zehani A, Chammakhi A, Rebai W, Kacem MJ. The management of hidradenitis suppurativa degenerating into squamous cell carcinoma: About three case reports. Ann Med Surg (Lond). 2021 Mar 24;64:102239.
Juviler PG, Patel AP, Qi Y. Infiltrative squamous cell carcinoma in hidradenitis suppurativa: A case report for early surgical intervention. Int J Surg Case Rep. 2019;55:50-53.
Yon JR, Son JD, Fredericks C, Morton M, Kingsley S, Gupta S, Poulakidas S, Bokhari F. Marjolin's Ulcer in Chronic Hidradenitis Suppurativa: A Rare Complication of an Often Neglected Disease. J Burn Care Res. 2017 Mar/Apr;38(2):121-124.
Racanelli E, Jfri A, Gefri A, O'Brien E, Litvinov IV, Zubarev A, Savin E, Netchiporouk E. Cutaneous Squamous Cell Carcinoma in Patients with Hidradenitis Suppurativa. Cancers (Basel). 2021 Mar 8;13(5):1153.
Matusiak L, Bieniek A, Szepietowski JC. Hidradenitis suppurativa markedly decreases quality of life and professional activity. J Am Acad Dermatol 2010;62(4):706-8, 708.e1.
Nguyen TV, Damiani G, Orenstein LAV, Hamzavi I, Jemec GB. Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life. J Eur Acad Dermatol Venereol. 2021 Jan;35(1):50-61.
Montero-Vilchez T, Diaz-Calvillo P, Rodriguez-Pozo JA, Cuenca-Barrales C, Martinez-Lopez A, Arias-Santiago S, Molina-Leyva A. The Burden of Hidradenitis Suppurativa Signs and Symptoms in Quality of Life: Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2021 Jun 22;18(13):6709.
Molina-Leyva A, Cuenca-Barrales C. Pruritus and Malodour in Patients with Hidradenitis Suppurativa: Impact on Quality of Life and Clinical Features Associated with Symptom Severity. Dermatology. 2020;236(1):59-65.
Alavi A, Farzanfar D, Lee RK, Almutairi D. The Contribution of Malodour in Quality of Life of Patients With Hidradenitis Suppurativa. J Cutan Med Surg. 2018 Mar/Apr;22(2):166-174.
Kontzias CL, Pixley JN, Feldman SR, Pichardo RO. Marriage Is Associated With Improved Social Support and Quality-of-Life in Hidradenitis Suppurativa. J Cutan Med Surg. 2023 Mar-Apr;27(2):178-179.
Wark KJL, Cains GD. The Microbiome in Hidradenitis Suppurativa: A Review. Dermatol Ther (Heidelb). 2021 Feb;11(1):39-52.
Williams SC, Frew JW, Krueger JG. A systematic review and critical appraisal of metagenomic and culture studies in hidradenitis suppurativa. Exp Dermatol. 2021 Oct;30(10):1388-1397.
Świerczewska Z, Lewandowski M, Surowiecka A, Barańska-Rybak W. Microbiome in Hidradenitis Suppurativa-What We Know and Where We Are Heading. Int J Mol Sci. 2022 Sep 24;23(19):11280.
Luck ME, Tao J, Lake EP. The Skin and Gut Microbiome in Hidradenitis Suppurativa: Current Understanding and Future Considerations for Research and Treatment. Am J Clin Dermatol. 2022 Nov;23(6):841-852.
Nesbitt E, Clements S, Driscoll M. A concise clinician's guide to therapy for hidradenitis suppurativa. Int J Womens Dermatol. 2019 Dec 27;6(2):80-84.
Zouboulis CC, Desai N, Emtestam L, Hunger RE, Ioannides D, Juhász I, Lapins J, Matusiak L, Prens EP, Revuz J, Schneider-Burrus S, Szepietowski JC, van der Zee HH, Jemec GB. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Eur Acad Dermatol Venereol. 2015 Apr;29(4):619-44.
Gener G, Canoui-Poitrine F, Revuz JE, Faye O, Poli F, Gabison G, Pouget F, Viallette C, Wolkenstein P, Bastuji-Garin S. Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients. Dermatology. 2009;219(2):148-54.
Dessinioti C, Zisimou C, Tzanetakou V, Stratigos A, Antoniou C. Oral clindamycin and rifampicin combination therapy for hidradenitis suppurativa: a prospective study and 1-year follow-up. Clin Exp Dermatol. 2016;41(8):852–857.
Join-Lambert O, Coignard H, Jais JP, Guet-Revillet H, Poirée S, Fraitag S, Jullien V, Ribadeau-Dumas F, Thèze J, Le Guern AS, Behillil S, Leflèche A, Berche P, Consigny PH, Lortholary O, Nassif X, Nassif A. Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa. Dermatology. 2011 Feb;222(1):49-58.
Delage M, Jais JP, Lam T, Guet-Revillet H, Ungeheuer MN, Consigny PH, Nassif A, Join-Lambert O. Rifampin-moxifloxacin-metronidazole combination therapy for severe Hurley stage 1 hidradenitis suppurativa: prospective short-term trial and 1-year follow-up in 28 consecutive patients. J Am Acad Dermatol. 2023 Jan;88(1):94-100.
Join-Lambert O, Coignard-Biehler H, Jais JP, Delage M, Guet-Revillet H, Poirée S, Duchatelet S, Jullien V, Hovnanian A, Lortholary O, Nassif X, Nassif A. Efficacy of ertapenem in severe hidradenitis suppurativa: a pilot study in a cohort of 30 consecutive patients. J Antimicrob Chemother. 2016 Feb;71(2):513-20.
Yazdanyar S, Boer J, Ingvarsson G, Szepietowski JC, Jemec GB. Dapsone therapy for hidradenitis suppurativa: a series of 24 patients. Dermatology. 2011;222:342–346.
Boer J, Nazary M. Long-term results of acitretin therapy for hidradenitis suppurativa. Is acne inversa also a misnomer? Br J Dermatol. 2011;164:170–175.
Matusiak L, Bieniek A, Szepietowski JC. Acitretin in hidradenitis suppurativa treatment – own experiences. Przegl Dermatol. 2012;99:356–357.
Golbari N.M., Porter M.L., Kimball A.B. Antiandrogen therapy with spironolactone for the treatment of hidradenitis suppurativa. J Am Acad Dermatol. 2019;80(1):114–119.
Arenbergerova M, Gkalpakiotis S, Arenberger P. Effective long-term control of refractory hidradenitis suppurativa with adalimumab after failure of conventional therapy. Int J Dermatol. 2010;49:1445–1449 .
Sotiriou E, Apalla Z, Vakirlis E, Ioannides D. Efficacy of adalimumab in recalcitrant hidradenitis suppurativa. Eur J Dermatol. 2009;19:180–181.
Paradela S, Rodriguez-Lojo R, Fernandez-Torres R, Arévalo P, Fonseca E. Long-term efficacy of infliximab in hidradenitis suppurativa. J Dermatolog Treat. 2012;23:278–283.
Lasocki A, Sinclair R, Foley P, Saunders H. Hidradenitis suppurativa responding to treatment with infliximab. Australas J Dermatol. 2010;51:186–190.
Takeda K, Kikuchi K, Kanazawa Y, Yamasaki K, Aiba S. Ustekinumab treatment for hidradenitis suppurativa. J Dermatol. 2019 Dec;46(12):1215-1218.
Tzanetakou V, Kanni T, Giatrakou S, Katoulis A, Papadavid E, Netea MG, Dinarello CA, van der Meer JWM, Rigopoulos D, Giamarellos-Bourboulis EJ. Safety and Efficacy of Anakinra in Severe Hidradenitis Suppurativa: A Randomized Clinical Trial. JAMA Dermatol. 2016 Jan;152(1):52-59.
Gracia Cazaña T, Berdel Díaz LV, Martín Sánchez JI, Querol Nasarre I, Gilaberte Y. Systematic Review of Light-Based Treatments for Hidradenitis Suppurativa. Actas Dermosifiliogr (Engl Ed). 2020 Mar;111(2):89-106.
Saunte DM, Lapins J. Lasers and Intense Pulsed Light Hidradenitis Suppurativa. Dermatol Clin. 2016 Jan;34(1):111-9.
Hamzavi I.H., Griffith J.L., Riyaz F., Hessam S., Bechara F.G. Laser and light-based treatment options for hidradenitis suppurativa. J Am Acad Dermatol. 2015;73(5 Suppl 1):S78–S81.
Mikkelsen P.R., Dufour D.N., Zarchi K., Jemec G.B. Recurrence rate and patient satisfaction of CO2 laser evaporation of lesions in patients with hidradenitis suppurativa: a retrospective study. Dermatol Surg. 2015;41(2):255–260.
Krakowski AC, Admani S, Uebelhoer NS, Eichenfield LF, Shumaker PR. Residual scarring from hidradenitis suppurativa: fractionated CO2 laser as a novel and noninvasive approach. Pediatrics. 2014 Jan;133(1):e248-51.
Verdolini R, Clayton N, Smith A, Alwash N, Mannello B. Metformin for the treatment of hidradenitis suppurativa: a little help along the way. J Eur Acad Dermatol Venereol. 2013 Sep;27(9):1101-8.
Jennings L, Hambly R, Hughes R, Moriarty B, Kirby B. Metformin use in hidradenitis suppurativa. J Dermatolog Treat. 2020 May;31(3):261-263.
Moussa C, Wadowski L, Price H, Mirea L, O'Haver J. Metformin as Adjunctive Therapy for Pediatric Patients With Hidradenitis Suppurativa. J Drugs Dermatol. 2020 Dec 1;19(12):1231-1234.
Brocard A., Knol A.C., Khammari A., Dréno B. Hidradenitis suppurativa and zinc: a new therapeutic approach. A pilot study. Dermatology. 2007;214(4):325–327.
Scuderi N, Monfrecola A, Dessy LA, Fabbrocini G, Megna M, Monfrecola G. Medical and Surgical Treatment of Hidradenitis Suppurativa: A Review. Skin Appendage Disord. 2017 May;3(2):95-110.
Shukla R, Karagaiah P, Patil A, Farnbach K, Ortega-Loayza AG, Tzellos T, Szepietowski JC, Giulini M, Schepler H, Grabbe S, Goldust M. Surgical Treatment in Hidradenitis Suppurativa. J Clin Med. 2022 Apr 21;11(9):2311.
van Hattem S, Spoo JR, Horváth B, Jonkman MF, Leeman FW. Surgical treatment of sinuses by deroofing in hidradenitis suppurativa. Dermatol Surg. 2012 Mar;38(3):494-7.
Menderes A., Sunay O., Vayvada H., Yilmaz M. Surgical management of hidradenitis suppurativa. Int J Med Sci. 2010;7(4):240–247.
Gierek M, Łabuś W, Słaboń A, Ziółkowska K, Ochała-Gierek G, Kitala D, Szyluk K, Niemiec P. Co-Graft of Acellular Dermal Matrix and Split Thickness Skin Graft-A New Reconstructive Surgical Method in the Treatment of Hidradenitis Suppurativa. Bioengineering (Basel). 2022 Aug 14;9(8):389
Stumpfe MC, Horch RE, Arkudas A, Cai A, Müller-Seubert W, Hauck T, Ludolph I. The Value of Negative-Pressure Wound Therapy and Flap Surgery in Hidradenitis Suppurativa - A Single Center Analysis of Different Treatment Options. Front Surg. 2022 Jun 28;9:867487.
Elboraey MA, Alali AB, Alkandari QA. Immediate and Delayed Reconstruction after Excision of Axillary Hidradenitis Suppurativa Using a Propeller Flap. Plast Reconstr Surg Glob Open. 2019 Aug 12;7(8):e2387.
Rieger UM, Erba P, Pierer G, Kalbermatten DF. Hidradenitis suppurativa of the groin treated by radical excision and defect closure by medial thigh lift: aesthetic surgery meets reconstructive surgery. J Plast Reconstr Aesthet Surg. 2009 Oct;62(10):1355-60.
Gierek M, Klama-Baryła A, Łabuś W, Bergler-Czop B, Pietrauszka K, Niemiec P. Platelet-Rich Plasma and Acellular Dermal Matrix in the Surgical Treatment of Hidradenitis Suppurativa: A Comparative Retrospective Study. J Clin Med. 2023 Mar 8;12(6):2112.
